Sunshine Heart Appoints New Director
ASX-listed heart device firm Sunshine Heart appoints US medtech executive Paul Buckman to its board, which now spans eight directors across Australia and the United States.
Chairman, Sunshine Heart, Inc.
Stories naming Nicholas Callinan. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
ASX-listed heart device firm Sunshine Heart appoints US medtech executive Paul Buckman to its board, which now spans eight directors across Australia and the United States.
Sunshine Heart's board will weigh ways to secure extra funding after starting its US heart device trial; finance chief Brian Bolton retires, with Rowena Hubble becoming company secretary.
Board change at Sunshine Heart: Nicholas Callinan takes the chairman role at the October 2008 annual meeting as Malcolm McComas steps down from it but stays a director; Callinan's venture capital career is profiled.